Literature DB >> 20523938

CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex.

Cornelia G Spruijt1, Stefanie J J Bartels, Arie B Brinkman, Jorrit V Tjeertes, Ina Poser, Hendrik G Stunnenberg, Michiel Vermeulen.   

Abstract

The Mi-2/NuRD (NUcleosome Remodeling and histone Deacetylase) chromatin remodeling complex is a large heterogeneous multiprotein complex associated with transcriptional repression. Here we apply a SILAC based quantitative proteomics approach to show that all known Mi-2/NuRD complex subunits co-purify with Cyclin Dependent Kinase 2 Associated Protein1 (CDK2AP1), also known as Deleted in Oral Cancer 1 (DOC-1). DOC-1 displays in vitro binding affinity for methylated DNA as part of the meCpG binding MBD2/NuRD complex. In luciferase reporter assays, DOC-1 is a potent repressor of transcription. Finally, immunofluorescence experiments reveal co-localization between MBD2 and DOC-1 in mouse NIH-3T3 nuclei. Collectively, these results indicate that DOC-1 is a bona fide subunit of the Mi-2/NuRD chromatin remodeling complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523938     DOI: 10.1039/c004108d

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  27 in total

1.  The nucleosome remodeling and deacetylase complex protein CHD4 regulates neural differentiation of mouse embryonic stem cells by down-regulating p53.

Authors:  Akira Hirota; May Nakajima-Koyama; Yuhei Ashida; Eisuke Nishida
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

2.  Human cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is dimeric in its disulfide-reduced state, with natively disordered N-terminal region.

Authors:  Asli Ertekin; James M Aramini; Paolo Rossi; Paul G Leonard; Haleema Janjua; Rong Xiao; Melissa Maglaqui; Hsiau-Wei Lee; James H Prestegard; Gaetano T Montelione
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

Review 3.  Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.

Authors:  D T W Wong; J J Kim; O Khalid; H H Sun; Y Kim
Journal:  J Dent Res       Date:  2011-08-24       Impact factor: 6.116

4.  CHD4 Is a Peripheral Component of the Nucleosome Remodeling and Deacetylase Complex.

Authors:  Jason K K Low; Sarah R Webb; Ana P G Silva; Hinnerk Saathoff; Daniel P Ryan; Mario Torrado; Mattias Brofelth; Benjamin L Parker; Nicholas E Shepherd; Joel P Mackay
Journal:  J Biol Chem       Date:  2016-05-27       Impact factor: 5.157

Review 5.  Structure and function insights into the NuRD chromatin remodeling complex.

Authors:  Morgan P Torchy; Ali Hamiche; Bruno P Klaholz
Journal:  Cell Mol Life Sci       Date:  2015-03-22       Impact factor: 9.261

6.  A novel regulatory factor recruits the nucleosome remodeling complex to wingless integrated (Wnt) signaling gene promoters in mouse embryonic stem cells.

Authors:  Jeffrey J Kim; Omar Khalid; Sheynie Vo; Ho-hyun Sun; David T W Wong; Yong Kim
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

Review 7.  The nucleosome remodeling and deacetylase complex in development and disease.

Authors:  Jeannine Basta; Michael Rauchman
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

Review 8.  The Methyl-CpG-Binding Domain 2 and 3 Proteins and Formation of the Nucleosome Remodeling and Deacetylase Complex.

Authors:  Gage Leighton; David C Williams
Journal:  J Mol Biol       Date:  2019-10-15       Impact factor: 5.469

9.  Cross-linking mass spectrometry reveals the structural topology of peripheral NuRD subunits relative to the core complex.

Authors:  Cornelia G Spruijt; Cathrin Gräwe; Simone C Kleinendorst; Marijke P A Baltissen; Michiel Vermeulen
Journal:  FEBS J       Date:  2020-12-14       Impact factor: 5.542

10.  Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences.

Authors:  Katharina Günther; Mareike Rust; Joerg Leers; Thomas Boettger; Maren Scharfe; Michael Jarek; Marek Bartkuhn; Rainer Renkawitz
Journal:  Nucleic Acids Res       Date:  2013-01-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.